Awal Khan

2.0k total citations
20 papers, 1.2k citations indexed

About

Awal Khan is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Awal Khan has authored 20 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 15 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in Awal Khan's work include Tuberculosis Research and Epidemiology (18 papers), Pneumocystis jirovecii pneumonia detection and treatment (9 papers) and HIV/AIDS drug development and treatment (5 papers). Awal Khan is often cited by papers focused on Tuberculosis Research and Epidemiology (18 papers), Pneumocystis jirovecii pneumonia detection and treatment (9 papers) and HIV/AIDS drug development and treatment (5 papers). Awal Khan collaborates with scholars based in United States, Uganda and Canada. Awal Khan's co-authors include William J. Burman, Andrew Vernon, Debra Benator, Lorna Bozeman, Marc Weiner, Stephen E. Weis, C. Robert Horsburgh, Timothy R. Sterling, Randall Reves and Andrew Vernon and has published in prestigious journals such as The Lancet, American Journal of Respiratory and Critical Care Medicine and Clinical Infectious Diseases.

In The Last Decade

Awal Khan

19 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Awal Khan United States	12	1.1k	860	478	99	91	20	1.2k
Jennifer Hughes South Africa	23	1.3k 1.2×	1.0k 1.2×	441 0.9×	52 0.5×	139 1.5×	56	1.5k
Sundari Mase United States	17	982 0.9×	751 0.9×	437 0.9×	38 0.4×	110 1.2×	41	1.1k
Michael E. Kimerling United States	20	1.1k 1.0×	885 1.0×	427 0.9×	54 0.5×	46 0.5×	35	1.2k
M. Gninafon Benin	14	599 0.6×	435 0.5×	244 0.5×	72 0.7×	73 0.8×	40	769
Chandrasekaran Padmapriyadarsini India	23	1.2k 1.1×	786 0.9×	353 0.7×	64 0.6×	98 1.1×	110	1.6k
Hee Jin Kim South Korea	19	1.1k 1.0×	892 1.0×	571 1.2×	25 0.3×	94 1.0×	76	1.4k
Andrea Benedetti Canada	23	1.6k 1.4×	1.1k 1.3×	688 1.4×	26 0.3×	77 0.8×	49	1.8k
Kidola Jeremiah Tanzania	20	831 0.8×	600 0.7×	301 0.6×	48 0.5×	50 0.5×	58	1.2k
James C.M. Brust United States	20	813 0.8×	687 0.8×	227 0.5×	32 0.3×	113 1.2×	34	1.0k
Els De Paepe Belgium	15	964 0.9×	679 0.8×	163 0.3×	40 0.4×	147 1.6×	28	1.2k

Countries citing papers authored by Awal Khan

Since Specialization

Citations

This map shows the geographic impact of Awal Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Awal Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Awal Khan more than expected).

Fields of papers citing papers by Awal Khan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Awal Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Awal Khan. The network helps show where Awal Khan may publish in the future.

Co-authorship network of co-authors of Awal Khan

This figure shows the co-authorship network connecting the top 25 collaborators of Awal Khan. A scholar is included among the top collaborators of Awal Khan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Awal Khan. Awal Khan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Regan, Mathilda, Garrett R. Beeler Asay, Ted Cohen, et al.. (2024). Racial and ethnic disparities in diagnosis and treatment outcomes among US-born people diagnosed with tuberculosis, 2003–19: an analysis of national surveillance data. The Lancet Public Health. 9(1). e47–e56. 5 indexed citations

Regan, Mathilda, Garrett R. Beeler Asay, Ted Cohen, et al.. (2024). Risk factors underlying racial and ethnic disparities in tuberculosis diagnosis and treatment outcomes, 2011–19: a multiple mediation analysis of national surveillance data. The Lancet Public Health. 9(8). e564–e572. 2 indexed citations

Marks, Suzanne M., Julie L. Self, Awal Khan, et al.. (2023). Diagnosis, Treatment, and Prevention of Tuberculosis Among People Experiencing Homelessness in the United States: Current Recommendations. Public Health Reports. 138(6). 896–907. 8 indexed citations

Njie, Gibril J. & Awal Khan. (2021). Prevalence of Tuberculosis and Mental Disorders Comorbidity: A Systematic Review and Meta-analysis. Journal of Immigrant and Minority Health. 24(6). 1550–1556. 6 indexed citations

Khan, Awal, et al.. (2021). Health Related Quality of Life in Systolic Heart Failure Patients at Tertiary Care Unit Cardiology OPD Hayatabad Medical Complex Peshawar Pakistan. Pakistan Journal of Public Health. 10(3). 140–146.

Friedman, Eleanor E., Awal Khan, & Wayne A. Duffus. (2018). Screening for Latent Tuberculosis Infection Among HIV-Infected Medicaid Enrollees. Public Health Reports. 133(4). 413–422. 1 indexed citations

Khan, Awal, et al.. (2018). Changes in Tuberculosis Disparities at a Time of Decreasing Tuberculosis Incidence in the United States, 1994–2016. American Journal of Public Health. 108(S4). S321–S326. 18 indexed citations

Moro, Ruth N., Andrey Borisov, Jussi Saukkonen, et al.. (2016). Factors Associated With Noncompletion of Latent Tuberculosis Infection Treatment: Experience From the PREVENT TB Trial in the United States and Canada. Clinical Infectious Diseases. 62(11). 1390–1400. 33 indexed citations

Reves, Randall, et al.. (2015). Tuberculosis Contact Investigations — United States, 2003–2012. MMWR Morbidity and Mortality Weekly Report. 64(50-51). 1369–1374. 30 indexed citations

10.

Balaban, Victor, Suzanne M. Marks, Sue C. Etkind, et al.. (2015). Tuberculosis Elimination Efforts in the United States in the Era of Insurance Expansion and the Affordable Care Act. Public Health Reports. 130(4). 349–354. 18 indexed citations

11.

Stout, Jason E., Andrzej S. Kosinski, Carol Hamilton, et al.. (2009). Effect of Improving the Quality of Radiographic Interpretation on the Ability to Predict Pulmonary Tuberculosis Relapse. Academic Radiology. 17(2). 157–162. 3 indexed citations

12.

Benator, Debra, Marc Weiner, William J. Burman, et al.. (2007). Clinical Evaluation of the Nelfinavir‐Rifabutin Interaction in Patients with Tuberculosis and Human Immunodeficiency Virus Infection. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 27(6). 793–800. 10 indexed citations

13.

Khan, Awal, Timothy R. Sterling, Randall Reves, Andrew Vernon, & C. Robert Horsburgh. (2006). Lack of Weight Gain and Relapse Risk in a Large Tuberculosis Treatment Trial. American Journal of Respiratory and Critical Care Medicine. 174(3). 344–348. 137 indexed citations

14.

Mosher, Ann, et al.. (2006). Factors associated with loss to follow-up in a large tuberculosis treatment trial (TBTC Study 22). Contemporary Clinical Trials. 28(3). 288–294. 11 indexed citations

15.

Burman, William J., Debra Benator, Andrew Vernon, et al.. (2005). Acquired Rifamycin Resistance with Twice-Weekly Treatment of HIV-related Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 173(3). 350–356. 109 indexed citations

16.

Weiner, Marc, Naomi Bock, Charles A. Peloquin, et al.. (2004). Pharmacokinetics of Rifapentine at 600, 900, and 1,200 mg during Once-Weekly Tuberculosis Therapy. American Journal of Respiratory and Critical Care Medicine. 169(11). 1191–1197. 62 indexed citations

17.

Jasmer, Robert M., Lorna Bozeman, Kevin Schwartzman, et al.. (2004). Recurrent Tuberculosis in the United States and Canada. American Journal of Respiratory and Critical Care Medicine. 170(12). 1360–1366. 105 indexed citations

18.

Weiner, Marc, William J. Burman, Andrew Vernon, et al.. (2003). Low Isoniazid Concentrations and Outcome of Tuberculosis Treatment with Once-Weekly Isoniazid and Rifapentine. American Journal of Respiratory and Critical Care Medicine. 167(10). 1341–1347. 151 indexed citations

19.

Benator, Debra, Mondira Bhattacharya, Lorna Bozeman, et al.. (2002). Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial. The Lancet. 360(9332). 528–534. 297 indexed citations

20.

Vernon, Andrew, William J. Burman, Debra Benator, Awal Khan, & Lorna Bozeman. (1999). Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. The Lancet. 353(9167). 1843–1847. 227 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact